About Shenandoah Biotechnology
Shenandoah Biotechnology is a company based in Horsham (United States) founded in 2006 was acquired by Irvine Scientific in March 2022. Shenandoah Biotechnology offers products and services including BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services. Shenandoah Biotechnology operates in a competitive market with competitors including PrognomiQ, PreOmics, Vivostat, List Biological Laboratories and LenioBio, among others.
- Headquarter Horsham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Irvine Scientific
(Mar 22, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Shenandoah Biotechnology
Shenandoah Biotechnology offers a comprehensive portfolio of products and services, including BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services.
Media for CHO cell culture in bioprocessing applications.
Media for immune and stem cell culture processes.
Proteins for research and therapeutic applications.
Tailored media optimization for specific needs.
Funding Insights of Shenandoah Biotechnology
Detailed funding history for Shenandoah Biotechnology
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Shenandoah Biotechnology
Shenandoah Biotechnology has secured backing from 1 investor. Prominent investors backing the company include Irvine Scientific.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Manufacture of cell culture media, reagents, and medical devices for researchers and clinicians
|
Locked | Locked | Locked |
Investor details for Shenandoah Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Shenandoah Biotechnology
Investment portfolio details for Shenandoah Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Shenandoah Biotechnology
Detailed financials for Shenandoah Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Shenandoah Biotechnology Comparisons
Peer comparison for Shenandoah Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Shenandoah Biotechnology
Shenandoah Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as PrognomiQ, PreOmics, Vivostat, List Biological Laboratories and LenioBio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of tests for the detection and treatment of cancer and other diseases
|
|
| Locked | Locked | Locked |
Reagents and instruments for proteomics research are supplied by PreOmics.
|
|
| Locked | Locked | Locked |
On-site fibrin sealant preparation systems are developed and provided.
|
|
| Locked | Locked | Locked |
Specializes in the production of research reagents
|
|
| Locked | Locked | Locked |
Kits for cell-free eukaryotic protein expression are provided.
|
|
| Locked | Locked | Locked |
Reagents and kits for protein-based research are developed and supplied.
|
Detailed competitors of Shenandoah Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Shenandoah Biotechnology
Complete news archive for Shenandoah Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shenandoah Biotechnology
Shenandoah Biotechnology was founded in 2006.
Shenandoah Biotechnology is headquartered in Horsham, United States. It is registered at Horsham, Pennsylvania, United States.
Pamela De Lacy is the current CEO of Shenandoah Biotechnology.
Shenandoah Biotechnology manufactures and supplies cytokines and recombinant protein products for research applications. The company specializes in the manufacture of recombinant proteins from E.coli, with their current product line mainly focused on recombinant cytokines, chemokines and growth factors typically used in a wide variety of research applications.
Shenandoah Biotechnology offers BalanCD CHO Media, PRIME-XV Media, Recombinant Proteins, and Custom Media Services.
Shenandoah Biotechnology has 1 investor. Key investors include Irvine Scientific.